Analysts at Sterne Agee downgraded Wells Fargo & Company (NYSE:

) from “buy” to “neutral.” The target price for Wells Fargo is set to $42. Wells Fargo's shares closed at $40.94 yesterday. Analysts at Bank of America downgraded Myriad Genetics (NASDAQ:

) from “buy” to “neutral.” The target price for Myriad Genetics has been lowered from $37 to $35. Myriad Genetics' shares closed at $32.01 yesterday. Analysts at Jefferies downgraded Southern Company (The) (NYSE:

) from “buy” to “hold.” The target price for Southern Company has been lowered from $53.50 to $44.65. Southern Company's shares closed at $44.65 yesterday. Goldman Sachs downgraded Rubicon Technology (NASDAQ:

) from “neutral” to “sell.” The target price for Rubicon Technology is set to $6. Rubicon Technology's shares closed at $7.88 yesterday.